Readers are directed to the PDF version of this article.
Publisher’s note: This guidance has been reviewed in 2020 and is considered to be out of date. Up-to-date guidance, including an algorithm for testing, can be found in this consensus statement.
SURMOUNT-5 trial pits tirzepatide against semaglutide, plus behaviour change support, for weight loss.
15 May 2025